Lung Cancer Screening
Chronic Obstructive Pulmonary Disease
Coronary artery Calcium scoring
Lung Cancer Screening
Chronic Obstructive Pulmonary Disease
Coronary artery Calcium scoring
Conformity Certifications
MFDS
Republic of Korea
FDA
United States of America
PMDA
Japan
TFDA
Taiwan
CE
Europe
TGA
Australia
HSA
Singapore
ANVISA
Brazil
HC
Canada
Automated Detection and Analysis Solution for
Lung Nodules, COPD, CAC
aview LCS PLUS can be also used as three individual products :
COPD, LCS and CAC
Emphysema
Emphysema Analysis
Translates low-dose chest CT images to analyze emphysema and automatically report the results. Converts and Analyzes emphysema with Low-dose CT images and generate automated comprehensive report.
Lung Nodule
Lung Nodules Detection and Analysis
Convert low-dose chest CT images to analyze lung nodules and automatically report the results.
Coronary Artery Calcium
Detection of calcium in the coronary artery
Convert low-dose chest CT images to find calcification
in the coronary artery and automatically
reports the results.
Supply of global lung cancer screening projects
aview is adopted as a lung cancer screening solution in five countries: South Korea, Germany, Italy, and five European countries
K-LUCAS
South Korea's lung cancer screening project
HANSE
Lung Cancer Screening Study in Germany
Hannover Medical School (MHH)
The University Medical Center Schleswig- Holstein, Lübeck Campus (UKSH)
LungenClinic Grosshansdorf
RISP
Italian Lung Screening Project
4-In-The-Lung-Run
Lung cancer screening project in five European countries
Netherlands, Germany, Spain, Italy and France
Publications
Refer to the following
research papers
These contents represent summaries of scientific
publications and are unrelated to any form of advertising.
Lung cancer is the cause of many deaths that could have been avoided if the disease had been detected at an early stage. Due to the heavy workload on the healthcare system, shortages of specialists, and expensive equipment, new solutions are needed to support the work of the hospitals. aview LCS PLUS is designed for the analysis of lung cancer, COPD, and CVD. By applying AI to disease detection, it can alleviate the strain on healthcare systems and ultimately save lives.
Joanna Bidzinska and Edyta Szurowska. “See Lung Cancer with an AI” Cancers.
The study aims to evaluate the use of automated coronary artery calcium (CAC) and quantitative emphysema (LAA) measurements in predicting mortality and lung cancer incidence during lung cancer screening. Additionally, it seeks to understand the relationships between LAA, CAC, forced expiratory value in 1 second (FEV1), and the ability of LAA to detect airflow obstruction. The LDCT images were analyzed using fully automated AI software (aview LCS PLUS, Coreline Soft) In a 6-year monitoring study involving 4,098 participants, the results revealed significant associations between increased age, male gender, a higher number of pack-years of smoking, and self-reported COPD with all mortality outcomes. LDCT biomarkers negatively correlated with FEV1, with %LAA enabling the identification of airflow obstruction with moderate discriminative ability.
Balbi M, Sabia F, Ledda RE, et al. “Automated Coronary Artery Calcium and Quantitative Emphysema in Lung Cancer Screening: Association With Mortality, Lung Cancer Incidence, and Airflow Obstruction.” J Thorac Imaging. 2023;38(4):W52-W63.
